Moreover, recombinant hRSPO1 injection promoted mucosal regeneration in models of DSS- or TNBS-induced colitis [106], and adenovirus-mediated delivery of hRSPO1 protected mice from 10.4 Gy whole-body irradiation and improved mortality rates [107]. This evidence concerns the gene RSPO1 and colitis.